Specimen considerations are critical for molecular testing as the majority of specimens consist of small biopsies or aspirates. We have modified our procedures to address this concern with a <3% QNS/failure rate.
| MLABS | OTHER LEADING LABORATORIES | ||||
| Mean (TAT) | ~7 days | ~12 days | |||
| Tissue Requirements | <1mm2 | >25mm2 | |||
| Tumor Content | ≥10% | ≥20% | |||
| QNS/Failure Rate | <3% | 15-20%Versatility of Accepted Specimens |
© 2019 MLabs. A Division of Pathology. Michigan Medicine. 